NovoCure Limited vs Pfizer, Inc. — Stock Comparison

NVCR
NovoCure Limited
$16.62
▲ 9.27%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5.4/10

Q·Score Breakdown

5.4
Bearish
Overall
6.5
Neutral
1
Quality
7.4
7.4
Health
7
6.7
Growth
5.6
6.5
Valuation
6.7
6.8
Sentiment
5.2
NVCR

Healthy balance sheet and financial position.

currently unprofitable (-26% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $25.21 (+51.7%)
7 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

NVCR
PFE
Trailing P/E
19.4×
-14.3×
Forward P/E
9.4×
-25.7%
Profit Margin
12.4%
75.4%
Gross Margin
75.8%
-50.0%
ROE
8.9%
12.3%
Revenue Growth
-1.2%
Earnings Growth
0.82
Beta
0.39
Price / Book
$1.9B
Market Cap
$149.8B
$10 – $20
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →